Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
Norovirus
|
455,498
|
14,693
|
B
|
Top
|
2
|
COVID-19 pandemic
|
286,334
|
9,236
|
GA
|
Top
|
3
|
COVID-19
|
190,470
|
6,144
|
B
|
Top
|
4
|
Polio
|
179,990
|
5,806
|
FA
|
Top
|
5
|
Epstein–Barr virus
|
154,697
|
4,990
|
B
|
Top
|
6
|
Measles
|
141,957
|
4,579
|
B
|
Top
|
7
|
Rabies
|
120,665
|
3,892
|
B
|
Top
|
8
|
HIV/AIDS
|
115,986
|
3,741
|
GA
|
Top
|
9
|
Dengue fever
|
111,382
|
3,592
|
FA
|
Top
|
10
|
List of epidemics and pandemics
|
107,833
|
3,478
|
List
|
High
|
11
|
Smallpox
|
105,640
|
3,407
|
GA
|
Top
|
12
|
Spanish flu
|
98,492
|
3,177
|
GA
|
Top
|
13
|
Prion
|
95,318
|
3,074
|
GA
|
Top
|
14
|
Molluscum contagiosum
|
85,688
|
2,764
|
B
|
High
|
15
|
Shingles
|
83,124
|
2,681
|
GA
|
Top
|
16
|
Respiratory syncytial virus
|
80,874
|
2,608
|
B
|
High
|
17
|
Human papillomavirus infection
|
80,059
|
2,582
|
B
|
Top
|
18
|
HIV
|
73,787
|
2,380
|
GA
|
Top
|
19
|
Virus
|
73,649
|
2,375
|
FA
|
Top
|
20
|
Influenza A virus
|
68,856
|
2,221
|
B
|
Top
|
21
|
Chickenpox
|
65,698
|
2,119
|
B
|
Top
|
22
|
Canine parvovirus
|
63,063
|
2,034
|
B
|
Top
|
23
|
Bell's palsy
|
61,510
|
1,984
|
B
|
Top
|
24
|
HPV vaccine
|
61,445
|
1,982
|
B
|
High
|
25
|
Creutzfeldt–Jakob disease
|
61,318
|
1,978
|
B
|
Top
|
26
|
Rosalind Franklin
|
58,987
|
1,902
|
B
|
High
|
27
|
Infectious mononucleosis
|
58,983
|
1,902
|
B
|
Top
|
28
|
Mumps
|
58,572
|
1,889
|
B
|
Top
|
29
|
Gastroenteritis
|
58,092
|
1,873
|
GA
|
Top
|
30
|
Influenza B virus
|
56,969
|
1,837
|
C
|
High
|
31
|
Rhinovirus
|
56,052
|
1,808
|
C
|
High
|
32
|
Hodgkin lymphoma
|
55,907
|
1,803
|
B
|
Top
|
33
|
COVID-19 lockdown in India
|
55,628
|
1,794
|
B
|
Mid
|
34
|
Rotavirus
|
53,703
|
1,732
|
FA
|
Top
|
35
|
Herpes
|
53,673
|
1,731
|
GA
|
Top
|
36
|
Herpes simplex virus
|
50,567
|
1,631
|
B
|
Top
|
37
|
Hand, foot, and mouth disease
|
50,298
|
1,622
|
B
|
High
|
38
|
Influenza
|
47,496
|
1,532
|
FA
|
High
|
39
|
Coronavirus
|
45,402
|
1,464
|
C
|
High
|
40
|
SARS-CoV-2
|
42,627
|
1,375
|
B
|
Top
|
41
|
Human metapneumovirus
|
40,883
|
1,318
|
C
|
High
|
42
|
Cytomegalovirus
|
40,586
|
1,309
|
B
|
Top
|
43
|
COVID-19 pandemic in the United States
|
38,000
|
1,225
|
B
|
Low
|
44
|
Yellow fever
|
37,397
|
1,206
|
B
|
Top
|
45
|
Edward Jenner
|
35,953
|
1,159
|
B
|
High
|
46
|
Timeline of the COVID-19 pandemic
|
35,898
|
1,158
|
List
|
Top
|
47
|
Rubella
|
34,182
|
1,102
|
B
|
Top
|
48
|
Canine distemper
|
34,063
|
1,098
|
B
|
Top
|
49
|
Variant Creutzfeldt–Jakob disease
|
34,003
|
1,096
|
B
|
High
|
50
|
Ebola
|
33,908
|
1,093
|
B
|
Top
|
51
|
Hepatitis C
|
33,763
|
1,089
|
GA
|
Top
|
52
|
Vaccine
|
33,122
|
1,068
|
B
|
Top
|
53
|
Croup
|
33,067
|
1,066
|
GA
|
Top
|
54
|
COVID-19 vaccine
|
32,407
|
1,045
|
B
|
Top
|
55
|
Common cold
|
31,068
|
1,002
|
GA
|
Top
|
56
|
Bacteriophage
|
30,274
|
976
|
B
|
Top
|
57
|
COVID-19 pandemic in India
|
29,541
|
952
|
B
|
High
|
58
|
History of HIV/AIDS
|
29,505
|
951
|
B
|
Top
|
59
|
HeLa
|
29,477
|
950
|
C
|
Mid
|
60
|
COVID-19 pandemic on cruise ships
|
29,214
|
942
|
B
|
High
|
61
|
Hepatitis B
|
28,536
|
920
|
GA
|
Top
|
62
|
Varicella zoster virus
|
27,325
|
881
|
C
|
High
|
63
|
COVID-19 lockdowns
|
26,887
|
867
|
B
|
Low
|
64
|
Adenoviridae
|
26,381
|
851
|
B
|
High
|
65
|
Pandemic
|
25,525
|
823
|
B
|
High
|
66
|
Chronic wasting disease
|
24,634
|
794
|
C
|
Top
|
67
|
List of COVID-19 vaccine authorizations
|
23,378
|
754
|
List
|
Mid
|
68
|
COVID-19 pandemic by country and territory
|
23,079
|
744
|
List
|
Top
|
69
|
Kaposi's sarcoma
|
23,027
|
742
|
C
|
Mid
|
70
|
Poliovirus
|
22,939
|
739
|
GA
|
High
|
71
|
Genital wart
|
22,658
|
730
|
B
|
Top
|
72
|
Messenger RNA
|
22,577
|
728
|
C
|
High
|
73
|
Cervical cancer
|
22,281
|
718
|
B
|
High
|
74
|
SARS
|
21,421
|
691
|
C
|
Top
|
75
|
Zidovudine
|
20,344
|
656
|
B
|
High
|
76
|
Smallpox vaccine
|
19,710
|
635
|
B
|
Mid
|
77
|
Epidemiology of HIV/AIDS
|
19,549
|
630
|
C
|
High
|
78
|
COVID-19 lab leak theory
|
18,988
|
612
|
C
|
Low
|
79
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
18,873
|
608
|
C
|
Low
|
80
|
Polio eradication
|
18,810
|
606
|
B
|
Mid
|
81
|
Feline leukemia virus
|
18,682
|
602
|
C
|
High
|
82
|
Foot-and-mouth disease
|
18,622
|
600
|
B
|
High
|
83
|
Cold sore
|
18,363
|
592
|
C
|
Top
|
84
|
Interferon
|
17,987
|
580
|
B
|
Top
|
85
|
Amantadine
|
17,839
|
575
|
C
|
High
|
86
|
Retrovirus
|
17,275
|
557
|
C
|
Top
|
87
|
Influenza A virus subtype H1N1
|
16,773
|
541
|
C
|
Top
|
88
|
Antiviral drug
|
16,594
|
535
|
C
|
Top
|
89
|
Genital herpes
|
16,544
|
533
|
C
|
High
|
90
|
Hepatitis A
|
16,314
|
526
|
B
|
Top
|
91
|
Origin of COVID-19
|
16,086
|
518
|
Start
|
Mid
|
92
|
Parvovirus B19
|
16,018
|
516
|
C
|
Mid
|
93
|
Remdesivir
|
15,975
|
515
|
C
|
High
|
94
|
West Nile virus
|
15,848
|
511
|
B
|
High
|
95
|
2009 swine flu pandemic
|
15,717
|
507
|
GA
|
High
|
96
|
Enterovirus
|
15,704
|
506
|
C
|
High
|
97
|
Varicella vaccine
|
15,341
|
494
|
B
|
Top
|
98
|
COVID-19 pandemic in the United Kingdom
|
15,186
|
489
|
C
|
Low
|
99
|
List of deaths due to COVID-19
|
14,709
|
474
|
List
|
High
|
100
|
HIV/AIDS in the United States
|
14,532
|
468
|
C
|
Low
|
101
|
Disease X
|
14,285
|
460
|
GA
|
Low
|
102
|
COVID-19 misinformation
|
13,832
|
446
|
C
|
Low
|
103
|
Zika virus
|
13,706
|
442
|
B
|
Top
|
104
|
Chikungunya
|
13,590
|
438
|
B
|
High
|
105
|
Vaccination
|
13,557
|
437
|
B
|
Top
|
106
|
Herpesviridae
|
13,369
|
431
|
C
|
Top
|
107
|
Coxsackievirus
|
13,357
|
430
|
C
|
High
|
108
|
Gardasil
|
13,232
|
426
|
B
|
High
|
109
|
Roseola
|
12,778
|
412
|
C
|
High
|
110
|
Mpox
|
12,563
|
405
|
C
|
High
|
111
|
Rinderpest
|
12,545
|
404
|
B
|
High
|
112
|
Measles vaccine
|
12,406
|
400
|
C
|
Low
|
113
|
Great Barrington Declaration
|
12,381
|
399
|
B
|
Low
|
114
|
COVID-19 pandemic in the Philippines
|
12,287
|
396
|
B
|
Low
|
115
|
Rabies virus
|
12,271
|
395
|
C
|
Top
|
116
|
2002–2004 SARS outbreak
|
12,060
|
389
|
B
|
Mid
|
117
|
Avian influenza
|
11,952
|
385
|
B
|
High
|
118
|
DNA polymerase
|
11,764
|
379
|
C
|
Top
|
119
|
COVID-19 pandemic deaths
|
11,530
|
371
|
C
|
Low
|
120
|
Marburg virus
|
11,434
|
368
|
C
|
High
|
121
|
Feline immunodeficiency virus
|
11,253
|
363
|
C
|
High
|
122
|
SARS-CoV-2 Omicron variant
|
11,210
|
361
|
C
|
High
|
123
|
Orthohantavirus
|
11,189
|
360
|
B
|
Top
|
124
|
Moderna
|
11,160
|
360
|
C
|
Low
|
125
|
Human parainfluenza viruses
|
11,103
|
358
|
C
|
Mid
|
126
|
Dengue vaccine
|
10,986
|
354
|
C
|
Low
|
127
|
Tobacco mosaic virus
|
10,759
|
347
|
C
|
High
|
128
|
Myxomatosis
|
10,454
|
337
|
GA
|
High
|
129
|
RNA interference
|
10,429
|
336
|
FA
|
High
|
130
|
Vaccine hesitancy
|
10,412
|
335
|
B
|
High
|
131
|
Timeline of HIV/AIDS
|
10,373
|
334
|
List
|
Mid
|
132
|
Reverse transcriptase
|
10,357
|
334
|
B
|
Top
|
133
|
Compartmental models in epidemiology
|
10,335
|
333
|
C
|
Mid
|
134
|
Dengue virus
|
10,321
|
332
|
B
|
Top
|
135
|
RNA polymerase
|
10,110
|
326
|
B
|
High
|
136
|
Index case
|
10,063
|
324
|
Start
|
Low
|
137
|
Virus classification
|
10,007
|
322
|
C
|
Top
|
138
|
Marburg virus disease
|
9,988
|
322
|
C
|
High
|
139
|
Hershey–Chase experiment
|
9,703
|
313
|
C
|
Mid
|
140
|
Pithovirus
|
9,651
|
311
|
C
|
High
|
141
|
Operation Warp Speed
|
9,642
|
311
|
C
|
High
|
142
|
Malaysian movement control order
|
9,544
|
307
|
B
|
Low
|
143
|
Western African Ebola virus epidemic
|
9,447
|
304
|
GA
|
Mid
|
144
|
Variants of SARS-CoV-2
|
9,230
|
297
|
C
|
Mid
|
145
|
SARS-CoV-1
|
9,181
|
296
|
C
|
High
|
146
|
COVID-19 pandemic in Australia
|
8,987
|
289
|
B
|
Low
|
147
|
Impact of the COVID-19 pandemic on cinema
|
8,783
|
283
|
B
|
Low
|
148
|
List of films impacted by the COVID-19 pandemic
|
8,731
|
281
|
List
|
Mid
|
149
|
Nipah virus
|
8,703
|
280
|
Start
|
Mid
|
150
|
Jonathan Van-Tam
|
8,593
|
277
|
C
|
Low
|
151
|
RNA virus
|
8,592
|
277
|
B
|
High
|
152
|
Hong Kong flu
|
8,561
|
276
|
C
|
Low
|
153
|
Japanese encephalitis
|
8,556
|
276
|
B
|
High
|
154
|
Impact of the COVID-19 pandemic on education
|
8,548
|
275
|
C
|
Low
|
155
|
COVID-19 pandemic in Italy
|
8,445
|
272
|
C
|
Mid
|
156
|
Parvoviridae
|
8,392
|
270
|
B
|
Mid
|
157
|
Host (biology)
|
8,351
|
269
|
GA
|
High
|
158
|
Viral disease
|
8,342
|
269
|
List
|
Top
|
159
|
COVID-19 pandemic in Maharashtra
|
8,334
|
268
|
C
|
Low
|
160
|
Attenuated vaccine
|
8,309
|
268
|
C
|
High
|
161
|
Viroid
|
8,228
|
265
|
C
|
High
|
162
|
COVID-19 pandemic in mainland China
|
8,205
|
264
|
C
|
High
|
163
|
Severe acute respiratory syndrome coronavirus 2
|
8,184
|
264
|
Redirect
|
NA
|
164
|
Walter Reed
|
8,088
|
260
|
C
|
Low
|
165
|
Human herpesvirus 6
|
8,040
|
259
|
C
|
High
|
166
|
Influenza vaccine
|
7,972
|
257
|
B
|
Top
|
167
|
COVID-19 pandemic in New Zealand
|
7,936
|
256
|
C
|
Low
|
168
|
Iridovirus
|
7,893
|
254
|
C
|
Low
|
169
|
Subacute sclerosing panencephalitis
|
7,865
|
253
|
C
|
Mid
|
170
|
Zaire ebolavirus
|
7,864
|
253
|
C
|
Top
|
171
|
Respiratory syncytial virus vaccine
|
7,856
|
253
|
B
|
Mid
|
172
|
Influenza A virus subtype H5N1
|
7,830
|
252
|
B
|
Top
|
173
|
Wuhan Institute of Virology
|
7,754
|
250
|
C
|
Mid
|
174
|
Hepatitis B virus
|
7,645
|
246
|
C
|
Top
|
175
|
Hammer-headed bat
|
7,632
|
246
|
GA
|
Low
|
176
|
Hepatitis C virus
|
7,607
|
245
|
B
|
Top
|
177
|
COVID-19 pandemic in Canada
|
7,603
|
245
|
B
|
Mid
|
178
|
Carcinogenesis
|
7,602
|
245
|
B
|
Mid
|
179
|
Feline infectious peritonitis
|
7,588
|
244
|
C
|
High
|
180
|
History of COVID-19 vaccine development
|
7,566
|
244
|
C
|
Low
|
181
|
Lysogenic cycle
|
7,504
|
242
|
C
|
High
|
182
|
Viral envelope
|
7,431
|
239
|
Start
|
Top
|
183
|
COVID-19 pandemic in Singapore
|
7,362
|
237
|
B
|
High
|
184
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
7,301
|
235
|
List
|
Low
|
185
|
SV40
|
7,207
|
232
|
C
|
Mid
|
186
|
Bioterrorism
|
7,151
|
230
|
B
|
Low
|
187
|
Transduction (genetics)
|
7,140
|
230
|
C
|
High
|
188
|
COVID-19 vaccination in India
|
7,048
|
227
|
C
|
Low
|
189
|
Cowpox
|
7,042
|
227
|
C
|
Mid
|
190
|
Human T-lymphotropic virus 1
|
7,017
|
226
|
C
|
High
|
191
|
Lambda phage
|
7,007
|
226
|
B
|
High
|
192
|
Face masks during the COVID-19 pandemic
|
6,997
|
225
|
B
|
Low
|
193
|
COVID-19 pandemic in the Republic of Ireland
|
6,961
|
224
|
C
|
Low
|
194
|
Phage therapy
|
6,923
|
223
|
C
|
Top
|
195
|
Travel during the COVID-19 pandemic
|
6,886
|
222
|
C
|
Low
|
196
|
Virology
|
6,859
|
221
|
B
|
Top
|
197
|
MERS
|
6,850
|
220
|
B
|
High
|
198
|
Swine influenza
|
6,843
|
220
|
B
|
High
|
199
|
Adeno-associated virus
|
6,819
|
219
|
B
|
High
|
200
|
Lyssavirus
|
6,815
|
219
|
C
|
Mid
|
201
|
Lady Mary Wortley Montagu
|
6,783
|
218
|
B
|
Low
|
202
|
Merkel-cell carcinoma
|
6,760
|
218
|
C
|
Mid
|
203
|
COVID-19 testing
|
6,751
|
217
|
B
|
Low
|
204
|
Metagenomics
|
6,722
|
216
|
GA
|
High
|
205
|
Economic impact of the COVID-19 pandemic
|
6,706
|
216
|
B
|
Low
|
206
|
Xenophobia and racism related to the COVID-19 pandemic
|
6,663
|
214
|
List
|
Low
|
207
|
Rabies in animals
|
6,618
|
213
|
C
|
High
|
208
|
Oncovirus
|
6,606
|
213
|
C
|
Top
|
209
|
Lentivirus
|
6,594
|
212
|
C
|
Mid
|
210
|
Impact of the COVID-19 pandemic on sports
|
6,584
|
212
|
C
|
Mid
|
211
|
Subtypes of HIV
|
6,552
|
211
|
C
|
High
|
212
|
Gain-of-function research
|
6,521
|
210
|
Start
|
High
|
213
|
Baltimore classification
|
6,521
|
210
|
B
|
Top
|
214
|
Orthomyxoviridae
|
6,517
|
210
|
B
|
High
|
215
|
Capsid
|
6,502
|
209
|
C
|
Top
|
216
|
Hantavirus pulmonary syndrome
|
6,464
|
208
|
Start
|
High
|
217
|
COVID-19 pandemic in Victoria
|
6,460
|
208
|
C
|
Low
|
218
|
Timeline of the COVID-19 pandemic in March 2020
|
6,439
|
207
|
List
|
High
|
219
|
Human coronavirus OC43
|
6,397
|
206
|
C
|
Mid
|
220
|
Borealpox virus (Alaskapox virus)
|
6,387
|
206
|
Start
|
Low
|
221
|
Henipavirus
|
6,368
|
205
|
C
|
High
|
222
|
Feline calicivirus
|
6,352
|
204
|
C
|
Top
|
223
|
Molnupiravir
|
6,327
|
204
|
C
|
Mid
|
224
|
Human polyomavirus 2
|
6,325
|
204
|
C
|
High
|
225
|
COVID-19 pandemic in the State of Palestine
|
6,305
|
203
|
Start
|
Low
|
226
|
Rubella virus
|
6,223
|
200
|
C
|
High
|
227
|
Koplik's spots
|
6,220
|
200
|
C
|
Mid
|
228
|
Viral hemorrhagic fever
|
6,145
|
198
|
C
|
High
|
229
|
Measles morbillivirus
|
6,132
|
197
|
C
|
Top
|
230
|
DNA virus
|
6,129
|
197
|
C
|
Top
|
231
|
History of smallpox
|
6,115
|
197
|
C
|
Mid
|
232
|
Herpes simplex encephalitis
|
6,103
|
196
|
Start
|
Low
|
233
|
Sapovirus
|
6,084
|
196
|
C
|
High
|
234
|
COVID-19 pandemic in South Africa
|
6,065
|
195
|
B
|
Mid
|
235
|
2022–2023 mpox outbreak
|
6,059
|
195
|
B
|
Mid
|
236
|
Virulence
|
6,045
|
195
|
C
|
High
|
237
|
Yellow fever vaccine
|
5,972
|
192
|
C
|
High
|
238
|
Astrovirus
|
5,877
|
189
|
B
|
Low
|
239
|
Escherichia virus T4
|
5,870
|
189
|
Start
|
Mid
|
240
|
2001 United Kingdom foot-and-mouth outbreak
|
5,861
|
189
|
C
|
Mid
|
241
|
Hepatitis E
|
5,857
|
188
|
GA
|
High
|
242
|
COVID-19 vaccine misinformation and hesitancy
|
5,825
|
187
|
B
|
Top
|
243
|
Lytic cycle
|
5,575
|
179
|
C
|
High
|
244
|
Poxviridae
|
5,571
|
179
|
C
|
High
|
245
|
COVID-19 pandemic in Hubei
|
5,531
|
178
|
C
|
Mid
|
246
|
Tick-borne encephalitis
|
5,516
|
177
|
Start
|
Low
|
247
|
Viral replication
|
5,473
|
176
|
C
|
Top
|
248
|
Rotavirus vaccine
|
5,451
|
175
|
C
|
High
|
249
|
COVID-19 pandemic in Europe
|
5,381
|
173
|
C
|
Low
|
250
|
Impact of the COVID-19 pandemic on the music industry
|
5,381
|
173
|
Start
|
Low
|
251
|
Sense (molecular biology)
|
5,377
|
173
|
C
|
High
|
252
|
Variolation
|
5,328
|
171
|
C
|
High
|
253
|
Papillomaviridae
|
5,323
|
171
|
B
|
Top
|
254
|
1889–1890 pandemic
|
5,271
|
170
|
C
|
Mid
|
255
|
Timeline of the COVID-19 pandemic in 2019
|
5,261
|
169
|
List
|
High
|
256
|
COVID-19 pandemic in British Columbia
|
5,208
|
168
|
B
|
Low
|
257
|
COVID-19 pandemic in Tamil Nadu
|
5,181
|
167
|
C
|
Low
|
258
|
COVID-19 pandemic in North Korea
|
5,180
|
167
|
B
|
Mid
|
259
|
COVID-19 pandemic in Germany
|
5,140
|
165
|
C
|
Low
|
260
|
COVID-19 pandemic in Sweden
|
5,134
|
165
|
B
|
Low
|
261
|
BK virus
|
5,128
|
165
|
B
|
Low
|
262
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
5,099
|
164
|
List
|
Low
|
263
|
Symptoms of COVID-19
|
5,091
|
164
|
C
|
Low
|
264
|
COVID-19 pandemic in New South Wales
|
5,056
|
163
|
B
|
Low
|
265
|
Flavivirus
|
5,044
|
162
|
B
|
High
|
266
|
Incertae sedis
|
5,036
|
162
|
C
|
Low
|
267
|
Adenovirus infection
|
5,019
|
161
|
Start
|
Mid
|
268
|
Influenza pandemic
|
5,000
|
161
|
B
|
Top
|
269
|
COVID-19 pandemic in Gujarat
|
4,964
|
160
|
Start
|
Low
|
270
|
Lassa fever
|
4,958
|
159
|
C
|
High
|
271
|
Kaposi's sarcoma-associated herpesvirus
|
4,929
|
159
|
C
|
High
|
272
|
Hepatitis D
|
4,927
|
158
|
C
|
Mid
|
273
|
Ebolavirus
|
4,887
|
157
|
C
|
Mid
|
274
|
Positive-strand RNA virus
|
4,866
|
156
|
C
|
High
|
275
|
Simian immunodeficiency virus
|
4,846
|
156
|
C
|
High
|
276
|
Xiangguo Qiu
|
4,835
|
155
|
Start
|
Low
|
277
|
Shope papilloma virus
|
4,764
|
153
|
C
|
Mid
|
278
|
COVID-19 pandemic in South Korea
|
4,728
|
152
|
B
|
Low
|
279
|
Picornavirus
|
4,703
|
151
|
B
|
Mid
|
280
|
Paramyxoviridae
|
4,685
|
151
|
C
|
High
|
281
|
SARS-CoV-2 Delta variant
|
4,655
|
150
|
C
|
Mid
|
282
|
Inclusion bodies
|
4,651
|
150
|
C
|
High
|
283
|
Strain (biology)
|
4,645
|
149
|
C
|
High
|
284
|
COVID-19 vaccination in the United States
|
4,591
|
148
|
Start
|
Low
|
285
|
Timeline of the COVID-19 pandemic in Canada
|
4,577
|
147
|
B
|
Mid
|
286
|
COVID-19 pandemic in Nepal
|
4,542
|
146
|
C
|
Low
|
287
|
Viral hepatitis
|
4,531
|
146
|
C
|
High
|
288
|
Monkeypox virus
|
4,519
|
145
|
C
|
Mid
|
289
|
Impact of the COVID-19 pandemic on commercial air transport
|
4,477
|
144
|
C
|
Low
|
290
|
Orthopoxvirus
|
4,473
|
144
|
C
|
High
|
291
|
U.S. state and local government responses to the COVID-19 pandemic
|
4,430
|
142
|
C
|
Mid
|
292
|
Ross River virus
|
4,418
|
142
|
C
|
Mid
|
293
|
COVID-19 pandemic in Oregon
|
4,401
|
141
|
B
|
Low
|
294
|
Pandemic H1N1/09 virus
|
4,385
|
141
|
C
|
Mid
|
295
|
Phage display
|
4,370
|
140
|
C
|
Mid
|
296
|
Human coronavirus HKU1
|
4,287
|
138
|
C
|
High
|
297
|
Timeline of the COVID-19 pandemic in India (January–May 2020)
|
4,214
|
135
|
B
|
High
|
298
|
COVID-19 pandemic in Mexico
|
4,213
|
135
|
C
|
Low
|
299
|
Anthony Epstein
|
4,209
|
135
|
Start
|
Mid
|
300
|
RNA-dependent RNA polymerase
|
4,208
|
135
|
C
|
Top
|
301
|
Timeline of the COVID-19 pandemic in January 2020
|
4,202
|
135
|
List
|
High
|
302
|
Mumps virus
|
4,188
|
135
|
B
|
High
|
303
|
COVID-19 pandemic in New York City
|
4,186
|
135
|
Start
|
Low
|
304
|
GS-441524
|
4,175
|
134
|
Start
|
Low
|
305
|
Negative-strand RNA virus
|
4,155
|
134
|
B
|
Mid
|
306
|
COVID-19 pandemic in California
|
4,153
|
133
|
C
|
Mid
|
307
|
COVID-19 pandemic in Japan
|
4,143
|
133
|
C
|
Low
|
308
|
Coronavirus spike protein
|
4,122
|
132
|
Start
|
Low
|
309
|
Crimean–Congo hemorrhagic fever
|
4,102
|
132
|
C
|
High
|
310
|
HIV vaccine development
|
4,093
|
132
|
C
|
Mid
|
311
|
COVID-19 pandemic in Malaysia
|
4,081
|
131
|
B
|
High
|
312
|
1977 Russian flu
|
4,074
|
131
|
C
|
Mid
|
313
|
Non-cellular life
|
4,058
|
130
|
Start
|
Low
|
314
|
History of virology
|
4,057
|
130
|
B
|
Top
|
315
|
COVID-19 lockdown in China
|
4,054
|
130
|
C
|
High
|
316
|
Timeline of the COVID-19 pandemic in Ontario (2020)
|
4,049
|
130
|
Start
|
Low
|
317
|
Virgin cleansing myth
|
4,031
|
130
|
Start
|
Low
|
318
|
Rolling circle replication
|
4,028
|
129
|
C
|
Mid
|
319
|
COVID-19 pandemic in Sri Lanka
|
4,019
|
129
|
C
|
Low
|
320
|
Diagnosis of HIV/AIDS
|
4,013
|
129
|
B
|
High
|
321
|
DNA vaccine
|
3,983
|
128
|
Start
|
Low
|
322
|
Giant virus
|
3,977
|
128
|
C
|
High
|
323
|
Rhabdoviridae
|
3,975
|
128
|
C
|
High
|
324
|
1978 smallpox outbreak in the United Kingdom
|
3,920
|
126
|
B
|
Low
|
325
|
COVID-19 pandemic on Diamond Princess
|
3,919
|
126
|
Start
|
Low
|
326
|
African swine fever virus
|
3,908
|
126
|
C
|
High
|
327
|
Arbovirus
|
3,878
|
125
|
C
|
Top
|
328
|
Zika fever
|
3,818
|
123
|
B
|
High
|
329
|
Ebola virus cases in the United States
|
3,810
|
122
|
C
|
High
|
330
|
Australian bat lyssavirus
|
3,801
|
122
|
C
|
Low
|
331
|
Vaccinia
|
3,795
|
122
|
C
|
High
|
332
|
West Nile fever
|
3,794
|
122
|
C
|
High
|
333
|
Echovirus
|
3,793
|
122
|
List
|
Mid
|
334
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
3,753
|
121
|
C
|
Mid
|
335
|
Timeline of the COVID-19 pandemic in New Zealand (2021)
|
3,745
|
120
|
List
|
Low
|
336
|
Endogenous retrovirus
|
3,724
|
120
|
C
|
Mid
|
337
|
Structure and genome of HIV
|
3,715
|
119
|
B
|
High
|
338
|
Congenital rubella syndrome
|
3,687
|
118
|
Start
|
Mid
|
339
|
Human alphaherpesvirus 1
|
3,663
|
118
|
Start
|
Mid
|
340
|
COVID-19 pandemic in Hong Kong
|
3,659
|
118
|
C
|
Low
|
341
|
Metapneumovirus
|
3,625
|
116
|
Stub
|
Mid
|
342
|
Plant virus
|
3,623
|
116
|
C
|
Top
|
343
|
Ebola vaccine
|
3,621
|
116
|
C
|
Mid
|
344
|
COVID-19 pandemic in Taiwan
|
3,620
|
116
|
C
|
Low
|
345
|
Solid lipid nanoparticle
|
3,613
|
116
|
C
|
Low
|
346
|
MERS-related coronavirus
|
3,575
|
115
|
B
|
High
|
347
|
Social impact of the COVID-19 pandemic in the Republic of Ireland
|
3,571
|
115
|
C
|
Low
|
348
|
Kyasanur Forest disease
|
3,515
|
113
|
B
|
Mid
|
349
|
Natural reservoir
|
3,500
|
112
|
C
|
High
|
350
|
Enhanced community quarantine in Luzon
|
3,489
|
112
|
B
|
Low
|
351
|
HBsAg
|
3,488
|
112
|
Start
|
High
|
352
|
Spike protein
|
3,476
|
112
|
Start
|
Low
|
353
|
Viral vector vaccine
|
3,448
|
111
|
Start
|
Low
|
354
|
National responses to the COVID-19 pandemic
|
3,448
|
111
|
C
|
Mid
|
355
|
Ivermectin during the COVID-19 pandemic
|
3,447
|
111
|
B
|
Low
|
356
|
B virus
|
3,447
|
111
|
C
|
Mid
|
357
|
U.S. federal government response to the COVID-19 pandemic
|
3,442
|
111
|
C
|
Mid
|
358
|
Timeline of the COVID-19 pandemic in the Republic of Ireland (2020)
|
3,440
|
110
|
C
|
Low
|
359
|
Discrimination against people with HIV/AIDS
|
3,389
|
109
|
C
|
High
|
360
|
List of diseases of the honey bee
|
3,387
|
109
|
List
|
High
|
361
|
Intracellular parasite
|
3,383
|
109
|
Start
|
Mid
|
362
|
Timeline of the COVID-19 pandemic in Ontario (2021)
|
3,368
|
108
|
C
|
Low
|
363
|
1957–1958 influenza pandemic
|
3,365
|
108
|
C
|
Mid
|
364
|
Feline coronavirus
|
3,364
|
108
|
C
|
Mid
|
365
|
Obelisk (biology)
|
3,361
|
108
|
Unknown
|
High
|
366
|
1793 Philadelphia yellow fever epidemic
|
3,354
|
108
|
C
|
Low
|
367
|
List of unproven methods against COVID-19
|
3,349
|
108
|
List
|
Mid
|
368
|
Lamivudine
|
3,346
|
107
|
C
|
Mid
|
369
|
Communication of the Trump administration during the COVID-19 pandemic
|
3,344
|
107
|
C
|
Low
|
370
|
Conjugate vaccine
|
3,322
|
107
|
C
|
High
|
371
|
Pod People (Invasion of the Body Snatchers)
|
3,313
|
106
|
Start
|
Low
|
372
|
Superinfection
|
3,303
|
106
|
Stub
|
Mid
|
373
|
Impact of the COVID-19 pandemic on the video game industry
|
3,283
|
105
|
C
|
Low
|
374
|
Timeline of the COVID-19 pandemic in New York City
|
3,275
|
105
|
Start
|
Low
|
375
|
COVID-19 pandemic in Kerala
|
3,267
|
105
|
C
|
Low
|
376
|
Impact of the COVID-19 pandemic on the environment
|
3,261
|
105
|
C
|
Low
|
377
|
Political impact of the COVID-19 pandemic
|
3,255
|
105
|
B
|
Low
|
378
|
Hendra virus
|
3,213
|
103
|
Start
|
Mid
|
379
|
Bluetongue disease
|
3,205
|
103
|
B
|
High
|
380
|
Molluscum contagiosum virus
|
3,163
|
102
|
C
|
Mid
|
381
|
COVID-19 pandemic in Bangladesh
|
3,155
|
101
|
Start
|
Mid
|
382
|
Marek's disease
|
3,153
|
101
|
C
|
Mid
|
383
|
Emerging infectious disease
|
3,150
|
101
|
Start
|
Low
|
384
|
COVID-19 pandemic in Pakistan
|
3,150
|
101
|
C
|
Low
|
385
|
Viral encephalitis
|
3,137
|
101
|
B
|
High
|
386
|
White House Coronavirus Task Force
|
3,115
|
100
|
C
|
Low
|
387
|
2020–21 Singapore circuit breaker measures
|
3,105
|
100
|
C
|
Low
|
388
|
Human coronavirus 229E
|
3,088
|
99
|
Start
|
Mid
|
389
|
COVID-19 pandemic in France
|
3,084
|
99
|
B
|
Mid
|
390
|
Face masks during the COVID-19 pandemic in the United States
|
3,083
|
99
|
C
|
Low
|
391
|
PEGylation
|
3,076
|
99
|
C
|
Low
|
392
|
COVID-19 pandemic in Jamaica
|
3,073
|
99
|
Start
|
Low
|
393
|
SARS-CoV-2 Alpha variant
|
3,072
|
99
|
C
|
Low
|
394
|
Viral evolution
|
3,049
|
98
|
C
|
High
|
395
|
COVID-19 pandemic in Afghanistan
|
3,047
|
98
|
C
|
Mid
|
396
|
Swedish government response to the COVID-19 pandemic
|
3,041
|
98
|
C
|
Low
|
397
|
List of biosafety level 4 organisms
|
3,038
|
98
|
List
|
Low
|
398
|
Virulent Newcastle disease
|
3,037
|
97
|
C
|
High
|
399
|
Vertically transmitted infection
|
3,036
|
97
|
C
|
High
|
400
|
HIV trial in Libya
|
3,031
|
97
|
B
|
Low
|
401
|
Viral shedding
|
3,027
|
97
|
Start
|
High
|
402
|
Human alphaherpesvirus 2
|
3,025
|
97
|
Start
|
Mid
|
403
|
Pleomorphism (microbiology)
|
3,020
|
97
|
C
|
High
|
404
|
COVID-19 pandemic in Israel
|
3,005
|
96
|
C
|
Mid
|
405
|
Priya Abraham
|
2,987
|
96
|
Start
|
Low
|
406
|
Vaccine shedding
|
2,985
|
96
|
Start
|
Mid
|
407
|
Human betaherpesvirus 5
|
2,984
|
96
|
C
|
High
|
408
|
Human coronavirus NL63
|
2,977
|
96
|
C
|
Low
|
409
|
Deployment of COVID-19 vaccines
|
2,975
|
95
|
C
|
High
|
410
|
Eastern equine encephalitis
|
2,964
|
95
|
C
|
Mid
|
411
|
Timeline of human vaccines
|
2,945
|
95
|
List
|
Low
|
412
|
COVID-19 pandemic in Russia
|
2,937
|
94
|
C
|
Low
|
413
|
Timeline of the COVID-19 pandemic in England (2021)
|
2,937
|
94
|
List
|
Low
|
414
|
Caliciviridae
|
2,904
|
93
|
C
|
Mid
|
415
|
HIV/AIDS in Russia
|
2,886
|
93
|
Start
|
Low
|
416
|
Pigeon pox
|
2,858
|
92
|
Stub
|
Low
|
417
|
COVID-19 pandemic in Turkmenistan
|
2,843
|
91
|
Start
|
Low
|
418
|
Double-stranded RNA viruses
|
2,842
|
91
|
Start
|
High
|
419
|
Primate T-lymphotropic virus
|
2,840
|
91
|
C
|
High
|
420
|
COVID-19 vaccination mandates in the United States
|
2,820
|
90
|
Start
|
Low
|
421
|
COVID-19 vaccination in Malaysia
|
2,819
|
90
|
C
|
Low
|
422
|
Influenza A virus subtype H3N2
|
2,818
|
90
|
C
|
High
|
423
|
SARS-related coronavirus
|
2,782
|
89
|
C
|
High
|
424
|
Alphavirus
|
2,781
|
89
|
B
|
Mid
|
425
|
Antibody-dependent enhancement
|
2,777
|
89
|
C
|
High
|
426
|
List of Ebola outbreaks
|
2,773
|
89
|
List
|
Low
|
427
|
Virus latency
|
2,765
|
89
|
C
|
High
|
428
|
COVID-19 vaccination in the United Kingdom
|
2,760
|
89
|
C
|
Low
|
429
|
Rift Valley fever
|
2,747
|
88
|
C
|
High
|
430
|
COVID-19 pandemic in Brazil
|
2,735
|
88
|
C
|
Low
|
431
|
Polyomaviridae
|
2,715
|
87
|
C
|
High
|
432
|
Heterophile antibody test
|
2,689
|
86
|
C
|
Low
|
433
|
Riboviria
|
2,689
|
86
|
B
|
Top
|
434
|
Reston virus
|
2,682
|
86
|
C
|
Low
|
435
|
Cytopathic effect
|
2,669
|
86
|
C
|
High
|
436
|
Superspreading event
|
2,667
|
86
|
C
|
High
|
437
|
Reverse-transcriptase inhibitor
|
2,664
|
85
|
C
|
High
|
438
|
Koilocyte
|
2,661
|
85
|
Start
|
Low
|
439
|
Negri body
|
2,657
|
85
|
Start
|
Mid
|
440
|
COVID-19 pandemic in New York (state)
|
2,642
|
85
|
C
|
Low
|
441
|
FFP standards
|
2,610
|
84
|
C
|
Mid
|
442
|
Treatment and management of COVID-19
|
2,602
|
83
|
C
|
Mid
|
443
|
Timeline of the COVID-19 pandemic in February 2020
|
2,597
|
83
|
List
|
High
|
444
|
COVID-19 pandemic in Vietnam
|
2,594
|
83
|
C
|
Low
|
445
|
HIV/AIDS in the Philippines
|
2,573
|
83
|
Start
|
Low
|
446
|
M13 bacteriophage
|
2,572
|
82
|
Start
|
Mid
|
447
|
Rabbit hemorrhagic disease
|
2,553
|
82
|
B
|
Mid
|
448
|
Bat virome
|
2,545
|
82
|
GA
|
High
|
449
|
COVID-19 pandemic in North America
|
2,542
|
82
|
C
|
Mid
|
450
|
Sedoreoviridae
|
2,535
|
81
|
C
|
Mid
|
451
|
Flat wart
|
2,529
|
81
|
Stub
|
Mid
|
452
|
Filoviridae
|
2,527
|
81
|
Start
|
High
|
453
|
Feed a cold, starve a fever
|
2,523
|
81
|
C
|
Low
|
454
|
Carnivore protoparvovirus 1
|
2,522
|
81
|
Start
|
Mid
|
455
|
COVID-19 pandemic in Africa
|
2,518
|
81
|
Start
|
Low
|
456
|
Viral pneumonia
|
2,508
|
80
|
Start
|
High
|
457
|
Mimivirus
|
2,501
|
80
|
C
|
Mid
|
458
|
Innate resistance to HIV
|
2,466
|
79
|
C
|
High
|
459
|
Coxsackie B virus
|
2,448
|
78
|
C
|
Mid
|
460
|
Tulip breaking virus
|
2,431
|
78
|
C
|
High
|
461
|
Yvonne Barr
|
2,418
|
78
|
Start
|
Low
|
462
|
COVID-19 pandemic in China
|
2,417
|
77
|
C
|
Mid
|
463
|
Impact of the COVID-19 pandemic on the arts and cultural heritage
|
2,413
|
77
|
C
|
Low
|
464
|
List of virus species
|
2,409
|
77
|
List
|
Top
|
465
|
History of the COVID-19 pandemic in the United Kingdom
|
2,407
|
77
|
C
|
High
|
466
|
Baculoviridae
|
2,407
|
77
|
C
|
Mid
|
467
|
Phi X 174
|
2,405
|
77
|
Start
|
Mid
|
468
|
Chinese government response to COVID-19
|
2,401
|
77
|
B
|
Mid
|
469
|
Oncolytic virus
|
2,392
|
77
|
B
|
Mid
|
470
|
Nipah virus infection
|
2,385
|
76
|
C
|
High
|
471
|
Richard H. Ebright
|
2,374
|
76
|
Start
|
Mid
|
472
|
Human betaherpesvirus 7
|
2,361
|
76
|
C
|
Mid
|
473
|
Influenza C virus
|
2,355
|
75
|
Start
|
Low
|
474
|
COVID-19 pandemic in the Czech Republic
|
2,352
|
75
|
C
|
Low
|
475
|
Ebola virus
|
2,352
|
75
|
Redirect
|
NA
|
476
|
Philippine government response to the COVID-19 pandemic
|
2,347
|
75
|
C
|
Low
|
477
|
White House COVID-19 outbreak
|
2,345
|
75
|
C
|
Low
|
478
|
Flaviviridae
|
2,343
|
75
|
Start
|
High
|
479
|
Lassa mammarenavirus
|
2,335
|
75
|
Start
|
Mid
|
480
|
Kivu Ebola epidemic
|
2,332
|
75
|
GA
|
High
|
481
|
Timeline of the COVID-19 pandemic in England (2022)
|
2,323
|
74
|
List
|
Low
|
482
|
COVID-19 pandemic in Indonesia
|
2,322
|
74
|
C
|
Low
|
483
|
Measles resurgence in the United States
|
2,318
|
74
|
C
|
Low
|
484
|
Spillover infection
|
2,280
|
73
|
Start
|
Mid
|
485
|
Timeline of the COVID-19 pandemic in Scotland (2021)
|
2,264
|
73
|
List
|
Low
|
486
|
HIV/AIDS in Thailand
|
2,253
|
72
|
Start
|
Low
|
487
|
Edible vaccine
|
2,245
|
72
|
C
|
Low
|
488
|
Banana bunchy top virus
|
2,244
|
72
|
C
|
Mid
|
489
|
COVID-19 pandemic in the Netherlands
|
2,229
|
71
|
C
|
Low
|
490
|
COVID-19 pandemic in Bulgaria
|
2,222
|
71
|
C
|
Mid
|
491
|
Severe fever with thrombocytopenia syndrome
|
2,204
|
71
|
Start
|
Low
|
492
|
COVID-19 pandemic in Delhi
|
2,202
|
71
|
C
|
Low
|
493
|
COVID-19 pandemic in Spain
|
2,201
|
71
|
C
|
Low
|
494
|
Timeline of the COVID-19 pandemic in April 2020
|
2,198
|
70
|
List
|
High
|
495
|
Impact of the COVID-19 pandemic on social media
|
2,196
|
70
|
Start
|
Low
|
496
|
Impact of the COVID-19 pandemic on television in the United States
|
2,193
|
70
|
C
|
Low
|
497
|
COVID-19 vaccination in Canada
|
2,192
|
70
|
B
|
Mid
|
498
|
COVID-19 pandemic in Florida
|
2,187
|
70
|
C
|
Low
|
499
|
2020 coronavirus pandemic in Germany
|
2,177
|
70
|
Redirect
|
NA
|
500
|
Psittacine beak and feather disease
|
2,169
|
69
|
Start
|
Mid
|